Alector (ALEC) Notes Payables (2025 - 2026)
Alector (ALEC) posted quarterly Notes Payables of $1.5 million for Q1 2026, up 304.37% quarter-over-quarter from $366000.0 in Q4 2025.
Alector (ALEC) Notes Payables (2025 - 2026) Analysis & Trends
Alector (ALEC) has reported Notes Payables for 2 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables changed N/A year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was $366000.0, changed N/A from the prior year.
- Notes Payables advanced to $1.5 million in Q1 2026 per ALEC's latest filing, from $366000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.5 million in Q1 2026 and bottomed at $366000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | 366,000.00 |